Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Frank Cornell

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Advances in Treatment of Cardiac AmyloidCherie N Dahm, R Frank Cornell, Daniel J Lenihan
Journal of Cardiac Failure|November 30, 2014
Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myelomaE Wilson Grandin, Bonnie Ky, R Frank Cornell, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2023
Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial DisparitiesJoseph Mikhael, Allie Cichewicz, Elizabeth S Mearns, et al.
JACC. Cardiooncology|December 7, 2020
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac AmyloidosisKathleen W Zhang, Jennifer Miao, Joshua D Mitchell, et al.
Plos One|July 8, 2020
Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosisElaine C Chen, Samuel Rubinstein, Cinque Soto, et al.
Bone Marrow Transplantation|April 29, 2018
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myelomaJennifer Huang, Sharon Phillips, Michael Byrne, et al.
Clinical Pharmacology and Therapeutics|February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization StudySamia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J Costa, Yi Lin, R Frank Cornell, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Advances in Treatment of Cardiac AmyloidCherie N Dahm, R Frank Cornell, Daniel J Lenihan
Journal of Cardiac Failure|November 30, 2014
Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myelomaE Wilson Grandin, Bonnie Ky, R Frank Cornell, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2023
Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial DisparitiesJoseph Mikhael, Allie Cichewicz, Elizabeth S Mearns, et al.
JACC. Cardiooncology|December 7, 2020
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac AmyloidosisKathleen W Zhang, Jennifer Miao, Joshua D Mitchell, et al.
Plos One|July 8, 2020
Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosisElaine C Chen, Samuel Rubinstein, Cinque Soto, et al.
Bone Marrow Transplantation|April 29, 2018
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myelomaJennifer Huang, Sharon Phillips, Michael Byrne, et al.
Clinical Pharmacology and Therapeutics|February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization StudySamia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J Costa, Yi Lin, R Frank Cornell, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Pageof 2